Everolimus Reverses Palbociclib Resistance in ER+ Human Breast Cancer Cells by Inhibiting Phosphatidylinositol 3-Kinase(PI3K)/Akt/Mammalian Target of Rapamycin (mTOR) Pathway

Lin Chen(Army Medical University), Hongming Dong(The First People’s Hospital of Lianyungang)
Medical Science Monitor
January 3, 2019
Cited by 25


Related Papers